Feifei Yang

May 29, 2024 | dovepress.com | Dan Wu |Fang Li |Feifei Yang |Jun Liu

Back to Journals » International Journal of General Medicine » Volume 17 Original ResearchInfectious Diseases Authors Wu D, Li F, Yang F, Liu J  Received 29 May 2024Accepted for publication 24 September 2024 Published 18 October 2024Volume 2024:17 Pages 4805—4814 DOI https://doi.org/10.2147/IJGM.S480411Checked for plagiarism YesReview by Single anonymous peer reviewPeer reviewer comments 3 Editor who approved publication: Prof.

Feb 15, 2024 | molecular-cancer.biomedcentral.com | Bo Huang |Qiang Ma |Feifei Yang |Xiaojuan Pan |Yuying Zhang |Yuying Liu | +8 more

We collected 152 paired human ccRCC and adjacent nontumor tissues (4 paired tissues for screening phase and 148 paired tissues for validation phase) from the Southwest Hospital of the Army Medical University (Chongqing, China, 2019–2022). Clinical characteristics are listed in Supplementary Table S1-2. The diagnosis of ccRCC was confirmed via histopathological examination. This study was approved by the Ethics Committee of Southwest Hospital of Army Medical University (approval number: KY2020121).

Apr 14, 2023 | dx.doi.org | Wei Zhou |Tianyu Zhang |Feifei Yang

The hydrodeoxygenation of phenolics is one of the key processes in lignin upgrading to fuel or aromatic products. MoS2-based catalysts show potential application in this reaction, and the defects are known to play an important role in phenolic C–O bond activation. However, the preparation of defective MoS2-based catalysts is usually complex. In this work, we report a facile synthesis of highly defective MoSxOy catalysts from MoS2 by the oxygen etching-reduction.